The Disruptive Nature of PBM Audits
Pharmacies understand how disruptive a PBM audit can be. These audits consume valuable time, threaten revenue, and can result in network termination. Following a PBM audit, many pharmacies are flagged for minor documentation errors and/or normal dispensing activity. Unfortunately, even small or inaccurate findings can lead to significant recoupment demands and lasting consequences such as network termination.
Common Audit Triggers: Prescription Volume and Dispensing Practices
Notably, one of the most common audit triggers involves unusually high prescription volumes, particularly when a pharmacy dispenses a large number of expensive or specialty drugs. PBMs also pay close attention to dispensing practices. Early refills or quantities that do not match plan limits often raise red flags, even if the discrepancy results from unintentional clerical mistakes. Prescriber patterns are another area of PBM focus. When most prescriptions originate from a single physician, or when providers are located far outside the pharmacy’s geographic area, PBMs frequently initiate deeper reviews and audits.
Claim Activity and Telehealth Scrutiny
Claim activity is another key factor in PBM audit selection. Pharmacies that generate frequent claim reversals or resubmissions may give the appearance of manipulating the system, which can trigger an audit, even when the reversals are routine or the result of innocent staff errors. In recent years, pharmacies that fill prescriptions originating from telehealth providers have also faced heightened scrutiny, as PBMs increasingly question the legitimacy of these prescribing relationships.
Reducing Audit Risks Through Preparation and Compliance
While it may not be possible to avoid every audit, pharmacies can take important steps to reduce audit risks. Careful preparation is essential. Pharmacies that maintain complete and accurate documentation, such as patient records, signature logs, and delivery confirmations, are in the strongest position to defend against adverse findings. Ongoing staff training and regular internal reviews of claims practices also help identify and correct potential issues before they attract PBM attention. By focusing on compliance and documentation, pharmacies can limit the likelihood of major recoupments or network sanctions.
The Importance of Legal Representation in PBM Audits
Even with careful preparation, however, PBM audits often result in findings that are unfair, exaggerated, or unsupported. At that stage, legal representation becomes critical. A knowledgeable PBM audit attorney can challenge improper conclusions, appeal recoupment demands, and protect a pharmacy’s ability to remain in network. Without strong advocacy, pharmacies often face unnecessary financial risk and network exclusions.
How Health Law Alliance Can Help
At Health Law Alliance, we represent pharmacies nationwide in all aspects of PBM audit defense. From proactive compliance strategies to aggressive appeals of audit findings, our PBM defense attorneys understand how PBMs operate and how to protect our clients’ interests. Contact Health Law Alliance today to schedule a consultation and learn how we can protect your pharmacy before, during, and after a PBM audit.
MORE ARTICLES BY CATEGORY
California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>OMIG Audit Defense New York: What the 2026 Work Plan Means for Providers
Every year, the New York Office of the Medicaid Inspector General (OMIG) releases its Work Plan outlining enforcement priorities. The 2026 plan sends a clear signal that Medicaid providers in New York are entering a far more aggressive enforcement environment.
Read More >>PBM Member Denial Audit Findings: A Growing Threat to Pharmacies
Pharmacies undergoing a Pharmacy Benefit Manager (PBM) audit are typically prepared to address inventory discrepancies and documentation issues. What many are not prepared for, however, is the increasing use of PBM member denial findings, allegations that a patient claims they did not receive and/or did not authorize the dispensing of a medication for which a claim was submitted.
Read More >>
